Damon Hostin leads the Precision Medicine Alliance of Catholic Health Initiatives and Dignity Health, bringing genomic solutions to over 150 hospitals. Prior, he was clinical business lead for Complete Genomics and Strategic Diagnostics. Earlier, Damon managed GenVis Labs, a genetic diagnostic company purchased by Pfizer. As a founding member of Actinium Pharmaceuticals, he managed alliances developing oncology therapeutics. As Team Leader, Sequencing at Celera Genomics he was published on the Human and Drosophila genomes and contributed to pharmaceutical partnerships. Damon's education includes undergraduate studies at Tulane University, Master's studies at Harvard University, and certificate programs at TIGR, NIH, and Wharton.